Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

BAX - Baxter International Inc.


Close
37.94
0.070   0.185%

Share volume: 4,248,878
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$37.87
0.07
0.19%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
42%
Profitability 39%
Dept financing 50%
Liquidity 19%
Performance 49%
Company vs Stock growth
vs
Performance
5 Days
1.84%
1 Month
6.46%
3 Months
15.36%
6 Months
-6.55%
1 Year
-6.07%
2 Year
-28.48%
Key data
Stock price
$37.94
P/E Ratio 
7.82
DAY RANGE
$37.74 - $38.47
EPS 
$4.88
52 WEEK RANGE
$30.05 - $43.29
52 WEEK CHANGE
-$0.04
MARKET CAP 
19.356 B
YIELD 
3.02%
SHARES OUTSTANDING 
510.178 M
DIVIDEND
$0.29
EX-DIVIDEND DATE
08/30/2024
NEXT EARNINGS DATE
10/31/2024
BETA 
0.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,865,249
AVERAGE 30 VOLUME 
$4,353,276
Company detail
CEO: Jose Almeida
Region: US
Website: https://www.baxter.com/
Employees: 32,403
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Recent news